Quantcast
Last updated on April 20, 2014 at 14:04 EDT

Latest Organovo Holdings Inc. Stories

2014-04-15 08:29:55

SAN DIEGO, April 15, 2014 /PRNewswire/ -- Organovo Holdings, Inc. (NYSE MKT: ONVO), the San Diego-based regenerative medicine company focused on using its breakthrough NovoGen 3D human tissue printing technology to create tissue on demand for medical research and therapeutic applications, today commented on recent reports published by two unaffiliated firms: "Over the past two months, new and unknown firms have issued articles and reports on Organovo, without speaking to Organovo...

2014-04-08 12:31:23

Company invites Main Street and Wall Street investors to attend interactive real-time virtual conference NEW YORK, April 8, 2014 /PRNewswire/ -- Organovo Holdings, Inc. (NYSE MKT: ONVO) the San Diego-based regenerative medicine company focused on using its breakthrough NovoGen 3D human tissue printing technology to create tissue on demand for medical research and therapeutic applications, today announced that Keith Murphy, CEO, will present at RetailInvestorConferences.com. DATE: April 10,...

2014-04-02 08:33:19

SAN DIEGO, April 2, 2014 /PRNewswire/ -- Organovo Holdings, Inc. (NYSE MKT: ONVO) ("Organovo"), a three-dimensional biology company focused on delivering breakthrough 3D bioprinting technology, has been invited to present at the 13(th) Annual Needham Healthcare Conference, which will be held in New York April 8-9, 2014. Organovo's Chairman and Chief Executive Officer, Keith Murphy, will be presenting at 8:40 am, April 9(th). The conference is being held at The Westin New York Grand...

2014-03-28 08:26:56

SAN DIEGO, March 28, 2014 /PRNewswire/ -- Organovo Holdings, Inc. (NYSE MKT: ONVO) ("Organovo"), a three-dimensional biology company focused on delivering breakthrough 3D bioprinting technology, today provided guidance on topics to be discussed at an upcoming Retail Investor Conference on April 10, 2014. Organovo's Chairman and Chief Executive Officer, Keith Murphy, will be presenting on Thursday, April 10, 2014 at 12:00pm ET, and investors can directly participate in this live,...

2014-03-24 08:28:40

SAN DIEGO, March 24, 2014 /PRNewswire/ -- Organovo Holdings, Inc. (NYSE MKT: ONVO) ("Organovo"), a three-dimensional biology company focused on delivering breakthrough 3D bioprinting technology, announced today that Barry Michaels, Chief Financial Officer, will present at the 2(nd) Annual Regen Med Investor Day to be held Wednesday, March 26, 2014 in New York City. Organized by the Alliance for Regenerative Medicine (ARM) in partnership with leading financial firms Maxim Group and...

2014-03-12 08:30:32

SAN DIEGO, March 12, 2014 /PRNewswire/ -- Organovo Holdings, Inc. (NYSE MKT: ONVO) ("Organovo"), a three-dimensional biology company focused on delivering breakthrough 3D bioprinting technology, today celebrated a profile of the company and the 3D bioprinting space as the cover story in the Economist's Technology Quarterly. Keith Murphy, chairman and chief executive officer of Organovo, commented that "Organovo is proud to continue to receive insightful coverage in top business and financial...

2014-02-21 08:25:36

SAN DIEGO, Feb. 21, 2014 /PRNewswire/ -- Organovo Holdings, Inc. (NYSE MKT: ONVO) ("Organovo"), a three-dimensional biology company focused on delivering breakthrough 3D bioprinting technology, announced today that it has been invited to participate at the Citi 2014 Global Healthcare Conference, which will be held in New York February 24 - 26, 2014. Organovo's Chief Technical Officer and Executive Vice President of Research and Development Dr. Sharon Presnell, will be participating...

2014-02-07 08:24:16

SAN DIEGO, Feb. 7, 2014 /PRNewswire/ -- Organovo Holdings, Inc. (NYSE MKT: ONVO) ("Organovo"), a three-dimensional biology company focused on delivering breakthrough 3D bioprinting technology, has reported its third quarter results and provided highlights of its recent activities. Keith Murphy, chairman and chief executive officer of Organovo, commented on the results. "The quarter continues our progress throughout our scientific, operational and business development activities. Our progress...

2014-01-29 08:30:15

SAN DIEGO, Jan. 29, 2014 /PRNewswire/ -- Organovo Holdings, Inc. (NYSE MKT: ONVO) ("Organovo"), a three-dimensional biology company focused on delivering breakthrough 3D bioprinting technology, today announced that it has performed its first 3D Liver tissue delivery. The achievement marks the delivery of Organovo's 3D Liver tissue to a laboratory outside of the company to a key opinion leader (KOL) for experimentation, and marks the achievement of a milestone along the pathway to commercial...

2014-01-14 08:29:32

SAN DIEGO and BETHESDA, Md., Jan. 14, 2014 /PRNewswire/ -- Organovo announced today that they are joining together with two institutes from the National Institutes of Health (NIH) to help scientists develop more reliable tools for bringing safer, more effective treatments to patients on a faster timeline. Organovo is collaborating with the National Center for Advancing Translational Sciences (NCATS) and the National Eye Institute (NEI) to develop better and more clinically predictive...